Our purpose is
to unlock the full potential of advanced therapies

Cytiva strengthens
cell line development with CEVEC acquisition

October 6, 2022


Dr. Nicole Faust has more than 20 years of management experience in the biotechnology sector. Before joining CEVEC, she held leadership positions with Lonza and Taconic Biosciences. She has a scientific background in stem cell biology and holds a PhD in cell and molecular biology from University of Freiburg and an MBA from Educatis University, Switzerland. She is a member of the American Society for Gene and Cell Therapy and currently Chair of the Gene Therapy Advisory Committee of the Alliance for Regenerative Medicine (ARM).


Managing Director

Dr. Ulrich Kettling is CBO at CEVEC Pharmaceuticals. Before joining CEVEC in 2018, Dr. Kettling served in various commercial and technical management positions both, in large multinational corporations and in smaller Biotechs, including Clariant; Süd-Chemie; Direvo Biotech. He graduated in Biotechnology and obtained a Ph.D. in Biophysical Chemistry at the Max Planck Institute in Göttingen.

DR. Ulrich Kettling

VP Commercial

© CEVEC Pharmaceuticals GmbH 2023